Microsoft word - customs rta exempt amdts sro 476 of 2011 affects_5.doc

EUS EXECUTIVE UPDATING SERVICE
Updating Acts, Ordinances, Statutory Rules & Orders (SROs.) etc. –––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– III-H 11/21 NAZIMABAD P. O. BOX 2140 KARACHI 74600 Ph: (92-21) 3662 0242-3 (NTN: 10 19 0347147) For EUS Clients’ Use Only
EUS UPDATE
GENERAL/RTA EXEMPTIONS
Removal of Tariff Anomalies (RTA)
Relevant Extract from Salient Features
(Relief Measures/Customs Budgetary Measures 2011-12)
Reduction of duty to 5% on pharmaceutical raw materials SRO. 567 (I)/2006 dated 05.06.2006 effective from 06.06.2006 [C. No. 3(3)TAR-I/2006 signed by the Additional Secretary, Mr. Shahid Ahmad], amended w.e.f. 04.06.2011 vide Revenue Division’s Budgetary SRO. 476 (I)/2011 dated 03.06.2011 [C.No. 2(2) Tar-I/2011 signed by the Additional Secretary, Mr. Mumtaz Haider Rizvi], in the following manner: Table-I (Specified Exemptions)
Input for Poultry Sector (S. No. 4)
Against PCT Heading “2923.9010”, the word “Betaine” substituted for “Betain”. Table-III (Pharmaceutical Manufacturing Exemptions)
Active Pharmaceutical Ingredients
Heading A substituted to read as follows:
ACTIVE PHARMACEUTICAL INGREDIENTS 1
ADDITIONS - Acrinol Pad, Amiloride HCL, Benzalkonium Chloride Pad
(BKC), Candesartan Cilextle, Cefotaxime, Ceftriaxone, Chondrotin Sulphate,
Clarithromycine
Glibenclamide, Hydrochlorothiazide, Isoniazid, Losartan Potassium, Omeprazole
Pellets, Pheneramine Maleate, Pioglitazone HCL, Polyethylene Film,
Roxithromycin, Sparfloxacin, and Thiocolchicoside, etc., as per EUS Comparing,
may be newly added Active Pharmaceutical Ingredients vide Budgetary SRO. 476
Description
Condition
[8] 2933.3990 Pantoprazole Sodium (Injec Grade) [15] 2933.5990 Protacine (Proglumet, Dimaleate) Numerical Order.––S. Nos. [5 to 47] are put into [brackets] due to disorder of
series for missing of No. 4 in the aforesaid amending notification. [42] 3005.9090 Benzalkonium Chloride Pad (BKC) **…*…**

Before Substitution by Revenue Division’s Budgetary SRO. 476
(I)/2011 dated 03.06.2011, Heading ‘A’ of Table-III (Pharmaceutical
Raw Materials, Chemicals, Finished Products if approved by the
Ministry of Health. Pharmaceutical Raw Materials, Chemicals &
Packing Materials shall only be allowed Concessions if imported for
In-House Use in the Manufacture of Specified Pharmaceutical
Substances) of SRO. 567 (I)/2006 dated 05.06.2006, wherein, Entries
in [Brackets] were earlier inserted/added w.e.f. 06.06.2010 vide
Budgetary SRO. 391 (I)/2010 dated 05.06.2010 [C.No.2(1)TAR-I/2010
signed by the Additional Secretary, Mr. Munir Qureshi], read as
follows:

“A. ACTIVE PHARMACEUTICAL INGREDIENTS
Description
Condition
[10A 2933.5990 Protacine (Proglumet, Dimaleate) **…*…**

Table-III (Pharmaceutical Manufacturing Exemptions)
Drugs (including Cancer, Cardiac, HIV/AIDS, Kidney,
Thalassaemia medicines & Hepatitis vaccines etc.) Heading C:
Against Sr. No. 6, after the PCT Heading “3002.2090”, Before aforesaid amendment Sr. No. 6 read as follows: **…*…**
EUS NOTICE BOARD
Executive Updating Service ( EUS ) takes no responsibility for any errors or omissions in its products/presentations/ updates, etc. It will be appreciated if any mistake is brought to our notice for correction henceforth. However, the Gazetted/Authority text is authentic for clear verdicts, which may be available on relevant websites. Further, overviews, comments or points etc. are given for reference only and Clients should not rely upon or act on EUS remarks, of which EUS is not held liable. EUS Clients/readers/viewers/visitors should consult their legal counsel for the opinions in their specific cases. for Executive Updating Service (EUS ) Copy Right Reserved
**…*…**

Source: http://eus.thedeviser.com/eus/wp-content/uploads/2012/04/Customs-RTA-Exempt-Amdts-SRO-476-of-2011-Affects.pdf